Lutz Achtnichts

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options

Ludwig Kappos, Till Sprenger, Christoph Stippich, 2016, PloS one.

Whole brain N-acetylaspartate concentration is conserved throughout normal aging

Achim Gass, Oded Gonen, Andreas U. Monsch, 2012, Neurobiology of Aging.

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis

Ludwig Kappos, Cristina Granziera, Henrik Zetterberg, 2017, Annals of neurology.

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Margaret Burnett, Gavin Giovannoni, 2018, The Lancet.